Swissmedic approves Novartis’ malaria medicine for babies

The treatment was developed in collaboration with Medicines for Malaria Venture. The Swiss Agency for Therapeutic Products (Swissmedic) has approved Novartis’ Coartem (artemether-lumefantrine) Baby, described as the first malaria medicine…